Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes
Zoltán Taybani1, Balázs Bótyik2, Mónika Katkó3
11st Department of Endocrinology, Dr. Réthy Pál Member Hospital, Békés County Central Hospital, Gyulai street 18, Békéscsaba, 5600, Hungary. taybanizoltan@gmail.com.
Switching type 2 diabetes patients from multiple daily injections (MDI) to once-daily IDegLira is safe and effective. This simplification led to improved glycemic control, weight loss, and reduced insulin needs, enhancing treatment adherence.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 2 diabetes management often involves multiple daily insulin injections (MDI).
- Simplifying treatment regimens is challenging due to lack of guidelines.
- Patients on MDI may remain on complex regimens even after glucose toxicity resolves.
Purpose of the Study:
- To evaluate the safety and efficacy of switching from MDI to once-daily IDegLira.
- To assess glycemic control and weight changes in type 2 diabetes patients.
- To examine the reduction in insulin requirements after regimen simplification.
Main Methods:
- 62 adults with type 2 diabetes on MDI were switched to once-daily IDegLira.
- IDegLira was self-titrated by patients to achieve pre-breakfast glucose < 6 mmol/L.
- Study assessed HbA1c, body weight, BMI, and hypoglycemia episodes.
Main Results:
- Mean HbA1c decreased by 0.30% to 6.12%.
- Mean body weight decreased by 3.11 kg, and BMI reduced.
- Hypoglycemia episodes significantly decreased from 45% to 9.67% of patients.
Conclusions:
- Switching from MDI to IDegLira is safe and effective for well-controlled type 2 diabetes.
- This simplification can lead to weight loss and improved glycemic control.
- Reduced insulin requirements and treatment burden may enhance therapy adherence.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...